Literature DB >> 10786820

Transforming growth factor-beta1 modulates chondrocyte responsiveness to 17beta-estradiol.

E Nasatzky1, D Grinfeld, B D Boyan, D D Dean, A Ornoy, Z Schwartz.   

Abstract

This study examined the interrelationship between transforming growth factor-beta1 (TGF-beta1) and 17beta-estradiol (E2) in the regulation of growth plate chondrocytes. To determine whether TGF-beta1 modulates chondrocyte response to E2, we used cells isolated from the resting zone (RC) and growth zone (GC) of costochondral cartilage. Confluent, fourth-passage cultures were pretreated with rhTGF-beta1 for 24 h, followed by treatment with E2 for 24 h. The effect of TGF-beta1 and E2 alone, or the sequential combination, were examined by measuring [3H]-thymidine incorporation (proliferation), alkaline phosphatase (AP) specific activity (differentiation), and [35S]-sulfate incorporation (matrix synthesis). TGF-beta1 alone increased [3H]-thymidine incorporation in both female and male RC and GC cells, but E2 affected this parameter only in RC cells, causing a dose-dependent decrease. At the highest concentration of TGF-beta1 and E2, [3H]-thymidine incorporation in female GC cells was the same as seen in untreated control cultures. In male GC cells, [3H]-thymidine incorporation in cultures treated with TGF-beta1 and E2 exhibited a comparable increase, as was seen in cultures treated with TGF-beta1 alone. TGF-beta1 caused a biphasic stimulation in AP that was maximal at 0.22 ng/mL, in both female and male RC and GC cells. E2, however, affected only female cells. Whereas the effect of TGF-beta1 predominated in RC and GC male cells, the biphasic stimulation caused by E2, maximal at 109 M, predominated in female RC cells. In female GC cells, however, TGF-beta1 caused a synergistic response, resulting in enhanced AP specific activity in cultures pretreated with 0.22 ng/mL of TGF-beta1 and 10(-8) M E2. TGF-beta1 alone caused dose-dependent increases in [35S]-sulfate incorporation in female RC and GC cells, as well as in male GC cells, but had no effect on male RC cells. E2 affected only female cells. TGF-beta1 potentiated the effect of E2 on this parameter, resulting in synergistic increases in the female cells. This is the first demonstration of a gender-specific response to TGF-beta1 in chondrocytes. These results suggest that chondrocyte response to a systemic hormone such as E2 can be modulated by local regulatory agents such as TGF-beta1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10786820     DOI: 10.1385/ENDO:11:3:241

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  51 in total

1.  Transforming growth factor beta mediates the estrogen induced inhibition of UMR106 cell growth.

Authors:  T K Gray; B Lipes; T Linkhart; S Mohan; D Baylink
Journal:  Connect Tissue Res       Date:  1989       Impact factor: 3.417

2.  Up-regulation of estrogen receptors in rabbit osteoarthritic cartilage.

Authors:  C L Tsai; T K Liu
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

3.  Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes.

Authors:  H A Pedrozo; Z Schwartz; T Mokeyev; A Ornoy; W Xin-Sheng; L F Bonewald; D D Dean; B D Boyan
Journal:  J Cell Biochem       Date:  1999-01-01       Impact factor: 4.429

4.  Latent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3.

Authors:  B D Boyan; Z Schwartz; S Park-Snyder; D D Dean; F Yang; D Twardzik; L F Bonewald
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

5.  Treatment of resting zone chondrocytes with transforming growth factor-beta 1 induces differentiation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25-(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3.

Authors:  Z Schwartz; V L Sylvia; Y Liu; D D Dean; B D Boyan
Journal:  Bone       Date:  1998-11       Impact factor: 4.398

6.  Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner.

Authors:  Z Schwartz; L F Bonewald; K Caulfield; B Brooks; B D Boyan
Journal:  Endocrinology       Date:  1993-04       Impact factor: 4.736

7.  Estrogen and glucocorticoid receptors in adult canine articular cartilage.

Authors:  P C Young; M T Stack
Journal:  Arthritis Rheum       Date:  1982-05

8.  The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro.

Authors:  B D Boyan; Z Schwartz; D L Carnes; V Ramirez
Journal:  Endocrinology       Date:  1988-06       Impact factor: 4.736

9.  Sex-dependent effects of 17-beta-estradiol on chondrocyte differentiation in culture.

Authors:  E Nasatzky; Z Schwartz; B D Boyan; W A Soskolne; A Ornoy
Journal:  J Cell Physiol       Date:  1993-02       Impact factor: 6.384

10.  Transforming growth factor-beta 1 (TGF-beta 1) up-regulation of collagen type II in primary cultures of rabbit articular chondrocytes (RAC) involves increased mRNA levels without affecting mRNA stability and procollagen processing.

Authors:  P Galéra; D Vivien; S Pronost; J Bonaventure; F Rédini; G Loyau; J P Pujol
Journal:  J Cell Physiol       Date:  1992-12       Impact factor: 6.384

View more
  3 in total

1.  Stathmin levels in growth plate chondrocytes are modulated by vitamin D3 metabolites and transforming growth factor-beta1 and are associated with proliferation.

Authors:  T W Hummert; Z Schwartz; V L Sylvia; D D Dean; B D Boyan
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

2.  Parathyroid hormone and transforming growth factor-beta1 coregulate chondrocyte differentiation in vitro.

Authors:  E Nasatzky; E Azran; D D Dean; B D Boyan; Z Schwartz
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

3.  Low bone mass resulting from impaired estrogen signaling in bone increases severity of load-induced osteoarthritis in female mice.

Authors:  Sophia N Ziemian; Olufunmilayo O Ayobami; Amanda M Rooney; Natalie H Kelly; Derek T Holyoak; F Patrick Ross; Marjolein C H van der Meulen
Journal:  Bone       Date:  2021-06-24       Impact factor: 4.398

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.